Michael Bennett

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery

Michael Bennett, Catherine L. Dent, Qing Ma et al. · Clinical Journal of the American Society of Nephrology · 2008 · 760 citations · Full text

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 688 citations · Full text

Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study

Catherine L. Dent, Qing Ma, Sudha Dastrala et al. · Critical Care · 2007 · 481 citations · Full text